Ankylosing spondylitis (AS), also called Bechterew’s disease is a form of arthritis that primarily affects the spine, although other joints may also be involved. It causes inflammation of the spinal joints (vertebrae) that can lead to severe, chronic pain and discomfort. It is a type of axial spondyloarthritis (axSpA) that refers to a particular form of spondyloarthritis in which the predominant symptom is inflammatory back pain.
Ankylosing spondylitis has no known specific cause, though genetic factors seem to be involved. In particular, people who have HLA-B27 genes are at increased risk of developing ankylosing spondylitis.
On the basis of severity, AS is classified as mild or early AS (stable AS) and severe or advanced AS (active). Early AS usually starts with dull pain in the lower back and the back stiffness, whereas severe AS is associated with continuous inflammation that leads to scarring and permanent damage.
Get FREE sample copy at:
The Ankylosing Spondylitis market report also covers emerging drugs, current treatment practices, Ankylosing Spondylitis market share of the individual therapies, current and forecasted Ankylosing Spondylitis Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Ankylosing Spondylitis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Ankylosing Spondylitis Market Key Facts
As per the DelveInsight, in 2017 there were 1,389,116 prevalent cases of Ankylosing Spondylitis in the 7MM. The prevalent cases are further expected to increase for the study period 2017–2030.
The United States accounts for the highest prevalent population of Ankylosing Spondylitis, followed by EU5 and Japan.
Among the European countries, Germany had the highest prevalent population of Ankylosing Spondylitis with 374,705 cases, followed by Italy with around 192,013 cases in 2017. Spain had the lowest prevalent pool of Ankylosing Spondylitis in 2017.
Key Benefits of Ankylosing Spondylitis Market Report
Ankylosing Spondylitis market report provides an in-depth analysis of Ankylosing Spondylitis Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Ankylosing Spondylitis market report will help in developing business strategies by understanding the Ankylosing Spondylitis Market trends & developments, key players and future market competition that will shape and drive the Ankylosing Spondylitis market in the upcoming years.
The Ankylosing Spondylitis market report covers Ankylosing Spondylitis current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Ankylosing Spondylitis market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
The Ankylosing Spondylitis market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Ankylosing Spondylitis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Ankylosing Spondylitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Ankylosing Spondylitis Epidemiology
The Ankylosing Spondylitis epidemiology section covers insights about historical and current Ankylosing Spondylitis patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Ankylosing Spondylitis Drugs Uptake and Key Market Players
The Ankylosing Spondylitis Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ankylosing Spondylitis market or expected to get launched in the market during the study period. The analysis covers Ankylosing Spondylitis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The key companies covered in the report includes:
Merck and Co.
And many others
Table of Contents
1. Key Insights
2. Executive Summary
3. Ankylosing Spondylitis Competitive Intelligence Analysis
4. Ankylosing Spondylitis Market Overview at a Glance
5. Ankylosing Spondylitis Disease Background and Overview
6. Ankylosing Spondylitis Patient Journey
7. Ankylosing Spondylitis Epidemiology and Patient Population
8. Ankylosing Spondylitis Treatment Algorithm, Current Treatment, and Medical Practices
9. Ankylosing Spondylitis Unmet Needs
10. Key Endpoints of Ankylosing Spondylitis Treatment
11. Ankylosing Spondylitis Marketed Products
12. Ankylosing Spondylitis Emerging Therapies
13. Ankylosing Spondylitis Seven Major Market Analysis
14. Attribute Analysis
15. Ankylosing Spondylitis Market Outlook (7 major markets)
16. Ankylosing Spondylitis Access and Reimbursement Overview
17. KOL Views on the Ankylosing Spondylitis Market.
18. Ankylosing Spondylitis Market Drivers
19. Ankylosing Spondylitis Market Barriers
21. DelveInsight Capabilities
DelveInsight’s Ankylosing Spondylitis (Bekhterev’s Disease) – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Ankylosing Spondylitis (Bekhterev’s Disease) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Ankylosing Spondylitis (Bekhterev’s Disease) Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Ankylosing Spondylitis (Bekhterev’s Disease) market.
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States